Cargando…
Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy
Mitophagy orchestrates the autophagic degradation of dysfunctional mitochondria preventing their pathological accumulation and contributing to cellular homeostasis. We previously identified a novel chemical tool (hereafter referred to as PMI), which drives mitochondria into autophagy without collaps...
Autores principales: | Georgakopoulos, Nikolaos D., Frison, Michele, Alvarez, Maria Soledad, Bertrand, Hélène, Wells, Geoff, Campanella, Michelangelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583253/ https://www.ncbi.nlm.nih.gov/pubmed/28871145 http://dx.doi.org/10.1038/s41598-017-07679-7 |
Ejemplares similares
-
PMI: A ΔΨ(m) Independent Pharmacological Regulator of Mitophagy
por: East, Daniel A., et al.
Publicado: (2014) -
Breast cancer cells exploit mitophagy to exert therapy resistance
por: Hardy, Liana, et al.
Publicado: (2018) -
Modified Peptide Inhibitors of the Keap1–Nrf2 Protein–Protein Interaction Incorporating Unnatural Amino Acids
por: Georgakopoulos, Nikolaos D., et al.
Publicado: (2018) -
The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
por: Frison, Michele, et al.
Publicado: (2021) -
Common Traits Spark the Mitophagy/Xenophagy Interplay
por: Singh, Aarti, et al.
Publicado: (2018)